Pharmacology of Insulin Injected With Jet-injection in Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diabetes Mellitus
Interventions
DEVICE

jet injection device

Rapid-acting insulin analogue aspart (Novorapid®) administration by means of a jet injector or a conventional insulin pen in the subcutaneous tissue. Dosage of insulin will be determined by the normal dosage of insulin used by the patient before breakfast.

Trial Locations (1)

6500 HB

Department of general internal medicine 463, section Diabetes, Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
collaborator

European Pharma Group (EPG)

UNKNOWN

lead

Radboud University Medical Center

OTHER

NCT01438632 - Pharmacology of Insulin Injected With Jet-injection in Diabetes | Biotech Hunter | Biotech Hunter